← Back
$ADMA All transactions

ADMA BIOLOGICS, INC.

▼ SELL 10b5-1 Plan

$ Value

$96K

Shares

6,000

Price

$16

Filed

Feb 17

Insider

Name

Grossman Adam S

Title

President and CEO

CIK

0001542517

Roles

Director Officer

Transaction Details

Transaction Date

2026-02-17

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

2,284,379

Footnotes

Transaction was effected pursuant to a Rule 10b5-1 trading plan entered into between the Reporting Person and Fidelity Brokerage Services LLC on November 14, 2025. | The price reported in Column 4 is the price at which the shares were sold. | Includes, as of the transaction date, (i) 282,529 unvested RSUs granted on February 9, 2026, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (ii) 252,022 unvested RSUs granted on February 19, 2025, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; | (continued from footnote 3) (iii) 418,296 unvested RSUs out of 557,728 RSUs granted on February 26, 2024, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (iv) 286,848 unvested RSUs out of 573,695 RSUs granted on March 6, 2023 that will vest quarterly on each annual anniversary of the date of grant, over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; | (continued from footnote 4) (v) 75,000 unvested RSUs out of 300,000 RSUs granted on March 7, 2022 that will vest quarterly on each annual anniversary of the date of grant, over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; and (vi) 969,684 shares of common stock owned by the Reporting Person, which reflects prior purchases and the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes. | These shares are owned by Areth, LLC ("Areth"). The Reporting Person is a control person of Areth. | These shares are owned by Hariden, LLC ("Hariden"). The Reporting Person is the managing member of Hariden. | The option was granted on February 26, 2024 and vests over four years with 25% of the shares of common stock underlying the option (i.e., 217,737 shares) vesting on February 26, 2025, the one-year anniversary of the date of grant, and the remaining 75% of such shares vesting monthly in equal installments over the next three years, becoming fully vested on February 26, 2028.

Filing Info

Accession No.

0001140361-26-005888

Form Type

4

Issuer CIK

0001368514

Grossman Adam S's History

Date Ticker Type Value
2026-03-16 ADMA M $81K
2026-03-16 ADMA $227K
2026-03-16 ADMA $91K
2026-03-16 ADMA M $0
2026-03-07 ADMA F $454K
2026-03-06 ADMA F $869K
2026-02-26 ADMA F $833K
2026-02-19 ADMA F $405K
2026-02-17 ADMA M $81K
2026-02-17 ADMA $241K

Other Insiders at ADMA (90d)

Insider Bought Sold Last
ELMS STEVE $217K 2026-03-06
Grossman Adam S
President and CEO
$560K 2026-03-16
Grossman Jerrold B 2026-02-09
Guiheen Lawrence P. 2026-03-17
FINGER ALISON CECILY 2026-02-09
KWON YOUNG 2026-02-09
Salas Eduardo Rene 2026-02-09
Kestenberg-Messina Kaitlin M.
COO and SVP, Compliance
$158K 2026-04-01
Tade Brad L.
CFO and Treasurer
2026-02-19